REMI Vigilenz AI for Event Detection
AI-based analysis of REMI EEG recordings to flag potential seizure events
ApprovedActive
Key Facts
Indication
AI-based analysis of REMI EEG recordings to flag potential seizure events
Phase
Approved
Status
Active
Company
About Epitel
Epitel, founded in 2016, is a private medical device and digital health company developing a novel, wireless EEG monitoring system called REMI. Its platform combines disposable, wearable sensors with cloud-based data transmission and an AI tool (REMI Vigilenz) for event detection, aiming to provide rapid, accurate, and patient-friendly neurological monitoring. The company targets the significant unmet need for accessible, long-term EEG monitoring in both hospital and home environments to improve the diagnosis and management of seizure disorders. Epitel's system is designed to be reimbursable and integrates with existing clinical EEG review software.
View full company profile